Bionano Genomics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Bionano Genomics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Bionano Genomics, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $816K, a 22% increase year-over-year.
  • Bionano Genomics, Inc. annual Operating Lease, Payments for 2024 was $2.75M, a 6.5% increase from 2023.
  • Bionano Genomics, Inc. annual Operating Lease, Payments for 2023 was $2.59M, a 59.4% increase from 2022.
  • Bionano Genomics, Inc. annual Operating Lease, Payments for 2022 was $1.62M, a 263% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.75M +$168K +6.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $2.59M +$964K +59.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $1.62M +$1.18M +263% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $447K +$447K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.